Pangaea Oncology, S.A. Stock BME
Equities
ES0105221008
Biotechnology & Medical Research
Sales 2023 * | 10.8M 11.56M 15.79M | Sales 2024 * | 16.2M 17.34M 23.68M | Capitalization | 50.35M 53.88M 73.6M |
---|---|---|---|---|---|
Net income 2023 * | - 0 0 | Net income 2024 * | - | EV / Sales 2023 * | 4.78 x |
Net Debt 2023 * | 1.3M 1.39M 1.9M | Net Debt 2024 * | 1.9M 2.03M 2.78M | EV / Sales 2024 * | 3.23 x |
P/E ratio 2023 * |
-85.5
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 21.08% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+48.49% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |